Nuvation Bio Inc.
4.57USD
-0.1300 (-2.77%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NUVB.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.1▲ | -$0.11 | 0 | 1 |
| Next quarter | -$0.09 | -$0.09 | 0 | 1 |
| Current year | -$0.29▼ | -$0.28 | 0 | 1 |
| Next year | -$0.02▲ | -$0.06 | 0 | 1 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.12 | -$0.15 | -0.03 (-25.2%) |
| 2026-03-31 | $0.05 | $0.04 | -0.01 (-23.6%) |
| 2025-12-31 | -$0.05 | -$0.09 | -0.04 (-91.1%) |
| 2025-09-30 | -$0.15 | -$0.14 | +0.01 (+7.0%) |
81 ratings from 16 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Initiated | Buy | $12 | Sep 30, 2026 |
| Citizens | Reiterated | Market Outperform | $10 | Sep 16, 2026 |
| Wedbush | Reiterated | Outperform | $11 | Sep 16, 2026 |
| Cantor Fitzgerald | Initiated | Overweight | — | Aug 21, 2026 |
| JP Morgan | Initiated | Overweight | $13 | Aug 18, 2026 |
| RBC Capital | Maintained | Outperform | $19 $20 | Aug 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $17 $21 | Jul 27, 2026 |
| Wedbush | Reiterated | Outperform | $11 | Jul 23, 2026 |
| RBC Capital | Maintained | Outperform | $20 $19 | Jul 7, 2026 |
| Truist Securities | Maintained | Buy | $12 $13 | Jul 7, 2026 |
| RBC Capital | Reiterated | Outperform | $20 | May 5, 2026 |
| Wedbush | Reiterated | Outperform | $11 | May 5, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $17 | May 5, 2026 |
| Wedbush | Reiterated | Outperform | $11 | Apr 16, 2026 |
| Wedbush | Reiterated | Outperform | $11 | Apr 2, 2026 |
| Wedbush | Reiterated | Outperform | $11 | Mar 27, 2026 |
| UBS | Maintained | Neutral | $10 $7 | Mar 3, 2026 |
| RBC Capital | Maintained | Outperform | $12 $13 | Mar 3, 2026 |
| Wedbush | Reiterated | Outperform | $11 | Feb 10, 2026 |
| RBC Capital | Maintained | Outperform | $9 $12 | Jan 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $18 $17 | Jan 12, 2026 |
| UBS | Initiated | Neutral | $10 | Jan 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10 $18 | Dec 11, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $10 | Dec 1, 2025 |
| Truist Securities | Initiated | Buy | $11 | Nov 24, 2025 |
44 filings from 12 insiders · 6 buy / 4 sell over 6m
Officers and directors of NUVB, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HATTERSLEY GARYOfficer | Exercise | 100.0k | $1.87 | $187k | Aug 19, 2026 |
| HATTERSLEY GARYOfficer | Sell | 100.0k | $7.09 | $709k | Aug 19, 2026 |
| SAUVAGE PHILIPPEChief Financial Officer | Exercise | 40.0k | $1.97 | $87k | Jul 15, 2026 |
| MARKEL STACYOfficer | Exercise | 125.0k | $1.74 | $229k | Jun 23, 2026 |
| SAUVAGE PHILIPPEChief Financial Officer | Exercise | 47.7k | $2.17 | $103k | Jun 23, 2026 |
| WENTWORTH KERRY AOfficer | Exercise | 63.0k | $2.93 | $185k | Jun 23, 2026 |
| SAUVAGE PHILIPPEChief Financial Officer | Sell | 47.7k | $6.01 | $286k | Jun 23, 2026 |
| WENTWORTH KERRY AOfficer | Sell | 63.0k | $6.02 | $379k | Jun 23, 2026 |
| MARKEL STACYOfficer | Sell | 125.0k | $6.03 | $753k | Jun 23, 2026 |
| MASHAL ROBERTDirector | Buyindirect | 25.0k | $4.73 | $118k | Jun 9, 2026 |
| LIU DONGFANGOfficer | Exercise | 50.0k | $1.94 | $97k | Apr 17, 2026 |
| WENTWORTH KERRY AOfficer | Exercise | 36.8k | $2.93 | $108k | Apr 17, 2026 |
| LIU DONGFANGOfficer | Sell | 50.0k | $5.02 | $251k | Apr 17, 2026 |
| WENTWORTH KERRY AOfficer | Sell | 36.8k | $5.01 | $184k | Apr 17, 2026 |
| WENTWORTH KERRY AOfficer | Exercise | 200.0k | $1.87 | $381k | Apr 6, 2026 |
| WENTWORTH KERRY AOfficer | Sell | 200.0k | $4.52 | $904k | Apr 6, 2026 |
| MAKUNJE MOSESOfficer | Grant | 50.8k | — | — | Feb 27, 2026 |
| LIU DONGFANGOfficer | Exercise | 150.0k | $2.93 | $440k | Dec 1, 2025 |
| LIU DONGFANGOfficer | Sell | 150.0k | $7.82 | $1.17M | Dec 1, 2025 |
| LIU DONGFANGOfficer | Exercise | 20.0k | $3.61 | $72k | Nov 26, 2025 |
No analyst notes on NUVB yet.
Members whose judged calls on NUVB have played out most reliably.
No settled calls on NUVB yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 9 | 1 | 0 | 0 | Buy1.85 |
| 1 mo ago | 3 | 9 | 1 | 0 | 0 | Buy1.85 |
| 2 mo ago | 3 | 8 | 1 | 0 | 0 | Buy1.83 |
| 3 mo ago | 2 | 7 | 1 | 0 | 0 | Buy1.90 |